{"id":"https://openalex.org/W2563735842","doi":"https://doi.org/10.1182/blood.v112.11.4012.4012","title":"Rasburicase Effectively Lowers Serum Uric Acid Levels in High Risk, Poor Performance Status Patients with Hematologic Malignancies","display_name":"Rasburicase Effectively Lowers Serum Uric Acid Levels in High Risk, Poor Performance Status Patients with Hematologic Malignancies","publication_year":2008,"publication_date":"2008-11-16","ids":{"openalex":"https://openalex.org/W2563735842","doi":"https://doi.org/10.1182/blood.v112.11.4012.4012","mag":"2563735842"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v112.11.4012.4012","doi":"https://doi.org/10.1182/blood.v112.11.4012.4012","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.4012.4012","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066163702","display_name":"Doris M. Ponce","orcid":"https://orcid.org/0000-0002-9422-5766","observed_orcids":["https://orcid.org/0000-0002-9422-5766"]},"institutions":[{"id":"https://openalex.org/I181190671","display_name":"New York Medical College","ror":"https://ror.org/03dkvy735","country_code":"US","type":"education","lineage":["https://openalex.org/I181190671"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Doris Ponce","raw_affiliation_strings":["New York Medical College, Valhalla, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York Medical College, Valhalla, NY, USA","institution_ids":["https://openalex.org/I181190671"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052008214","display_name":"Delong Liu","orcid":"https://orcid.org/0000-0003-4502-4949","observed_orcids":["https://orcid.org/0000-0003-4502-4949","https://orcid.org/0000-0001-9956-0857"]},"institutions":[{"id":"https://openalex.org/I181190671","display_name":"New York Medical College","ror":"https://ror.org/03dkvy735","country_code":"US","type":"education","lineage":["https://openalex.org/I181190671"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Delong Liu","raw_affiliation_strings":["New York Medical College, Valhalla, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York Medical College, Valhalla, NY, USA","institution_ids":["https://openalex.org/I181190671"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Muhammad Rasul","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181190671","display_name":"New York Medical College","ror":"https://ror.org/03dkvy735","country_code":"US","type":"education","lineage":["https://openalex.org/I181190671"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Muhammad Rasul","raw_affiliation_strings":["New York Medical College, Valhalla, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York Medical College, Valhalla, NY, USA","institution_ids":["https://openalex.org/I181190671"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109610120","display_name":"Nasir Uddin Ahmed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181190671","display_name":"New York Medical College","ror":"https://ror.org/03dkvy735","country_code":"US","type":"education","lineage":["https://openalex.org/I181190671"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nasir Ahmed","raw_affiliation_strings":["New York Medical College, Valhalla, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York Medical College, Valhalla, NY, USA","institution_ids":["https://openalex.org/I181190671"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002552687","display_name":"Marie Dimicco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1321686444","display_name":"Westchester Medical Center","ror":"https://ror.org/03fcgva33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1321686444"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marie Dimicco","raw_affiliation_strings":["Westchester Medical Center, Valhalla, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Westchester Medical Center, Valhalla, NY, USA","institution_ids":["https://openalex.org/I1321686444"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084409602","display_name":"Karen P. Seiter","orcid":"https://orcid.org/0000-0003-3838-7901","observed_orcids":["https://orcid.org/0000-0003-3838-7901"]},"institutions":[{"id":"https://openalex.org/I181190671","display_name":"New York Medical College","ror":"https://ror.org/03dkvy735","country_code":"US","type":"education","lineage":["https://openalex.org/I181190671"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Seiter","raw_affiliation_strings":["New York Medical College, Valhalla, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York Medical College, Valhalla, NY, USA","institution_ids":["https://openalex.org/I181190671"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.37634448,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":95},"biblio":{"volume":"112","issue":"11","first_page":"4012","last_page":"4012"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12845","display_name":"Methemoglobinemia and Tumor Lysis Syndrome","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12845","display_name":"Methemoglobinemia and Tumor Lysis Syndrome","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rasburicase","display_name":"rasburicase","score":0.996999979019165},{"id":"https://openalex.org/keywords/serum-uric-acid","display_name":"serum uric acid","score":0.9020000100135803},{"id":"https://openalex.org/keywords/tumor-lysis-syndrome","display_name":"tumor lysis syndrome","score":0.8740000128746033},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.8740000128746033},{"id":"https://openalex.org/keywords/hyperuricemia","display_name":"hyperuricemia","score":0.8529999852180481},{"id":"https://openalex.org/keywords/kidney-failure","display_name":"renal failure","score":0.7039999961853027},{"id":"https://openalex.org/keywords/urate-oxidase","display_name":"uricase","score":0.8080000281333923},{"id":"https://openalex.org/keywords/allopurinol","display_name":"allopurinol","score":0.8889999985694885},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.7860000133514404},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.8769999742507935},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.6679999828338623},{"id":"https://openalex.org/keywords/poor-performance-status","display_name":"poor performance status","score":0.7360000014305115},{"id":"https://openalex.org/keywords/high-dose-chemotherapy","display_name":"high-dose chemotherapy","score":0.5009999871253967},{"id":"https://openalex.org/keywords/hyper-cvad","display_name":"hyper-CVAD","score":0.6380000114440918},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.7720000147819519}],"concepts":[{"id":"https://openalex.org/C2778939600","wikidata":"https://www.wikidata.org/wiki/Q3088229","display_name":"Rasburicase","level":4,"score":0.9936290383338928},{"id":"https://openalex.org/C2779721657","wikidata":"https://www.wikidata.org/wiki/Q49970","display_name":"Hyperuricemia","level":3,"score":0.8656363487243652},{"id":"https://openalex.org/C2780261098","wikidata":"https://www.wikidata.org/wiki/Q412486","display_name":"Allopurinol","level":2,"score":0.8247150182723999},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7740118503570557},{"id":"https://openalex.org/C2779788671","wikidata":"https://www.wikidata.org/wiki/Q998803","display_name":"Tumor lysis syndrome","level":3,"score":0.7721929550170898},{"id":"https://openalex.org/C2779881121","wikidata":"https://www.wikidata.org/wiki/Q105522","display_name":"Uric acid","level":2,"score":0.7603984475135803},{"id":"https://openalex.org/C2776073210","wikidata":"https://www.wikidata.org/wiki/Q409804","display_name":"Allantoin","level":2,"score":0.756627082824707},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.69142085313797},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6418137550354004},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4992961883544922},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.4332568049430847},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.37814128398895264},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.05740088224411011},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v112.11.4012.4012","doi":"https://doi.org/10.1182/blood.v112.11.4012.4012","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.4012.4012","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2979836548","https://openalex.org/W2565885465","https://openalex.org/W2000214427","https://openalex.org/W2039839320","https://openalex.org/W2019077795","https://openalex.org/W2026969800","https://openalex.org/W2039488099","https://openalex.org/W97122436","https://openalex.org/W2001895853","https://openalex.org/W2012091585"],"abstract_inverted_index":{"Abstract":[0],"Tumor":[1],"lysis":[2],"remains":[3],"a":[4,55,63,77,95,109,221,273,315,344],"significant":[5],"cause":[6],"of":[7,28,47,50,90,103,154,187,213,303,311,330,338,352,357,370],"morbidity":[8],"and":[9,21,35,52,98,240,297,336,363],"mortality":[10],"in":[11,31,54,62,108,305,314,318,333],"patients":[12,128,209,219,247,271,288,312,325,342,359],"with":[13,71,135],"highly":[14],"proliferative":[15],"hematologic":[16,126],"malignancies.":[17],"Traditionally,":[18],"intravenous":[19],"hydration":[20],"oral":[22],"allopurinol":[23,73],"have":[24],"been":[25],"the":[26,45,114,133,349],"mainstays":[27],"therapy.":[29,74],"However":[30,112],"some":[32,341],"patients,":[33],"hyperuricemia":[34],"renal":[36,42,334],"failure":[37,43],"still":[38],"occur.":[39],"The":[40,101,141,224,257],"resultant":[41],"precludes":[44],"administration":[46,337],"full":[48],"doses":[49],"chemotherapy":[51,372],"results":[53,102],"poor":[56,345],"treatment":[57],"outcome.":[58],"Recently":[59],"we":[60,118],"participated":[61],"large":[64],"phase":[65],"III":[66],"randomized":[67],"trial":[68],"comparing":[69],"rasburicase":[70,138,214,304],"standard":[72,197],"Rasburicase":[75],"is":[76],"recombinant":[78],"urate":[79],"oxidase":[80],"that":[81,104],"effectively":[82],"reduces":[83],"serum":[84,250,274,319],"uric":[85,91,226,251,320],"acid":[86,92,227,252,321],"due":[87,347],"to":[88,291,348,366],"conversion":[89],"into":[93],"allantoin,":[94],"readily":[96],"excretable":[97],"soluble":[99],"substance.":[100],"study":[105,115,134,144],"are":[106],"reported":[107],"separate":[110],"abstract.":[111],"while":[113],"was":[116,261],"open,":[117],"treated":[119],"12":[120,358],"extremely":[121,307],"high":[122,202,308],"risk,":[123],"newly":[124],"diagnosed":[125],"malignancy":[127],"who":[129],"were":[130,146,364],"ineligible":[131],"for":[132,143,328],"commercially":[136],"available":[137],"off":[139],"study.":[140],"reasons":[142],"ineligibility":[145],"ECOG":[147],"Performance":[148],"Status":[149],"4":[150,192,356],"and/or":[151],"expected":[152],"survival":[153],"less":[155,276],"than":[156,277],"one":[157,211],"month.":[158],"Other":[159],"baseline":[160,259],"characteristics:":[161],"Diagnosis:":[162],"Burkitts":[163],"ALL:":[164],"3,":[165],"AML:":[166],"7,":[167],"CML-BP:":[168],"1,":[169],"T-ALL:":[170],"1;":[171],"Age:":[172],"64":[173],"(27\u201385),":[174],"Sex:":[175],"6M/6F;":[176],"WBC:":[177],"58,000/mm3":[178],"(1.6-":[179],"245,000);":[180],"LDH:":[181],"2201":[182],"U/l":[183],"(1068-":[184],">2500);":[185],"#":[186],"preexisting":[188],"comorbid":[189],"medical":[190],"conditions:":[191],"(0\u20137);":[193],"chemotherapy:":[194],"hyper-CVAD:":[195],"4,":[196],"ara-c":[198],"based":[199,205],"rx:":[200,206],"5,":[201],"dose":[203,212],"ara-C":[204],"3.":[207],"Nine":[208],"received":[210],"(0.2":[215],"mg/kg":[216],"IV),":[217],"3":[218,298],"required":[220],"second":[222],"dose.":[223],"median":[225,258,282],"levels":[228],"were:":[229],"pretreatment":[230],":":[231],"9.2":[232],"mg/dl":[233,263,279],"(2.8\u201328.6),":[234],"at":[235,241],"24":[236],"hours:":[237,243],"<0.2":[238,244],"(0.2\u20137.5)":[239],"48":[242],"(<0.2\u20134.9).":[245],"All":[246],"achieved":[248,289],"normal":[249],"level":[253],"by":[254,267],"day":[255,268],"2.":[256],"creatinine":[260,275,283],"2.6":[262],"(0.7":[264],"\u2013":[265],"5.6);":[266],"seven":[269],"10":[270],"had":[272,294,299,343],"2":[278],"(day":[280],"7":[281],"0.9,":[284],"range":[285],"0.4\u20135.5).":[286],"Four":[287],"CR":[290,362],"chemotherapy,":[292],"5":[293],"refractory":[295],"disease":[296],"induction":[300],"death.":[301],"Administration":[302],"this":[306,326],"risk":[309],"group":[310],"resulted":[313],"rapid":[316],"decrease":[317],"levels.":[322],"In":[323],"many":[324],"allowed":[327],"preservation":[329],"or":[331],"improvement":[332],"function":[335],"chemotherapy.":[339],"Although":[340],"outcome":[346],"aggressive":[350],"nature":[351],"their":[353],"underlying":[354],"disease,":[355],"(33%)":[360],"attained":[361],"able":[365],"receive":[367],"subsequent":[368],"cycles":[369],"intensive":[371],"without":[373],"incident.":[374]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-18T09:31:52.927876","created_date":"2017-01-06T00:00:00"}